|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Axovant Gene Therapies Ltd. (AXON)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-12-18 Purchase |
2018-12-20 09:38 am |
Axovant Sciences Ltd. | AXON | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities LP Viking Global Equities II LP VGE III Portfolio Ltd. Viking Long Fund Master Ltd. Viking Long Fund GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
10,000,000 | $1 | $10,000,000 | 99,285,712 (Indirect) |
View |
| 2018-12-18 Purchase |
2018-12-20 09:37 am |
Axovant Sciences Ltd. | AXON | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
10,000,000 | $1 | $10,000,000 | 99,285,712 (Indirect) |
View |
| 2018-12-18 Purchase |
2018-12-20 08:57 am |
Axovant Sciences Ltd. | AXON | Lo Andrew 10% Owner |
10,000,000 | $1 | $10,000,000 | 99,285,712 (Indirect) |
View |
| 2018-12-18 Purchase |
2018-12-20 07:29 am |
Axovant Sciences Ltd. | AXON | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner |
10,000,000 | $1 | $10,000,000 | 99,285,712 (Indirect) |
View |
| 2018-12-18 Purchase |
2018-12-20 07:06 am |
Axovant Sciences Ltd. | AXON | SVF Investments (UK) Ltd SVF GP (Jersey) Ltd SoftBank Vision Fund L.P. SVF Holdings (UK) LLP 10% Owner |
10,000,000 | $1 | $10,000,000 | 99,285,712 (Indirect) |
View |
| 2018-12-18 Purchase |
2018-12-20 06:15 am |
Axovant Sciences Ltd. | AXON | QVT Associates GP LLC QVT Offshore Ltd. 10% Owner |
10,000,000 | $1 | $10,000,000 | 99,285,712 (Indirect) |
View |
| 2018-12-18 Purchase |
2018-12-20 06:03 am |
Axovant Sciences Ltd. | AXON | Machado Patrick 10% Owner |
10,000,000 | $1 | $10,000,000 | 99,285,712 (Indirect) |
View |
| 2018-12-18 Purchase |
2018-12-20 06:02 am |
Axovant Sciences Ltd. | AXON | Roivant Sciences Ltd. 10% Owner |
10,000,000 | $1 | $10,000,000 | 99,285,712 (Direct) |
View |
| 2018-08-09 Purchase |
2018-08-13 5:26 pm |
Axovant Sciences Ltd. | AXON | Bickerstaff George Director |
25,000 | $2.07 | $51,750 | 50,000 (Direct) |
View |
| 2018-06-05 Purchase |
2018-06-07 08:46 am |
Axovant Sciences Ltd. | AXON | Lo Andrew 10% Owner |
14,285,714 | $1.75 | $25,000,000 | 89,285,712 (Indirect) |
View |
| 2018-06-05 Purchase |
2018-06-07 08:43 am |
Axovant Sciences Ltd. | AXON | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner |
14,285,714 | $1.75 | $25,000,000 | 89,285,712 (Indirect) |
View |
| 2018-06-05 Purchase |
2018-06-07 08:38 am |
Axovant Sciences Ltd. | AXON | QVT Associates GP LLC QVT Fund V LP 10% Owner |
14,285,714 | $1.75 | $25,000,000 | 89,285,712 (Indirect) |
View |
| 2018-06-05 Purchase |
2018-06-07 08:24 am |
Axovant Sciences Ltd. | AXON | SVF Investments (UK) Ltd SVF Holdings (UK) LLP SVF GP (Jersey) Ltd SoftBank Vision Fund L.P. 10% Owner |
14,285,714 | $1.75 | $25,000,000 | 89,285,712 (Indirect) |
View |
| 2018-06-05 Purchase |
2018-06-07 08:21 am |
Axovant Sciences Ltd. | AXON | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities LP Viking Global Equities II LP VGE III Portfolio Ltd. Viking Long Fund Master Ltd. Viking Long Fund GP LLC 10% Owner |
14,285,714 | $1.75 | $25,000,000 | 89,285,712 (Indirect) |
View |
| 2018-06-05 Purchase |
2018-06-07 08:20 am |
Axovant Sciences Ltd. | AXON | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
14,285,714 | $1.75 | $25,000,000 | 89,285,712 (Indirect) |
View |
| 2018-06-05 Purchase |
2018-06-07 07:32 am |
Axovant Sciences Ltd. | AXON | Machado Patrick 10% Owner |
14,285,714 | $1.75 | $25,000,000 | 89,285,712 (Indirect) |
View |
| 2018-06-05 Purchase |
2018-06-07 07:31 am |
Axovant Sciences Ltd. | AXON | Roivant Sciences Ltd. 10% Owner |
14,285,714 | $1.75 | $25,000,000 | 89,285,712 (Direct) |
View |
| 2018-02-27 Purchase |
2018-03-01 4:43 pm |
Axovant Sciences Ltd. | AXON | Bickerstaff George Director |
25,000 | $1.497 | $37,425 | 25,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-10-15 Option Award |
2018-10-16 6:05 pm |
N/A 2028-10-14 |
Axovant Sciences Ltd. | AXON | POTTER MYRTLE S Director |
150,000 | $2.37 | 150,000 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-16 6:02 pm |
N/A 2028-10-14 |
Axovant Sciences Ltd. | AXON | Torti Frank Director |
150,000 | $2.37 | 150,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 8:18 pm |
N/A 2028-09-30 |
Axovant Sciences Ltd. | AXON | Bazley Mathew C. General Counsel |
250,000 | $2.28 | 250,000 (Direct) |
View |
| 2018-10-01 Option Award |
2018-10-03 8:18 pm |
N/A 2028-09-30 |
Axovant Sciences Ltd. | AXON | Bazley Mathew C. General Counsel |
200,000 | $2.28 | 250,000 (Direct) |
View |
| 2018-08-15 Option Award |
2018-08-17 5:26 pm |
N/A 2028-08-14 |
Axovant Sciences Ltd. | AXON | Lombardo Ilise Chief Medical Officer |
100,000 | $2.02 | 100,000 (Direct) |
View |
| 2018-07-16 Option Award |
2018-07-20 6:23 pm |
N/A 2028-07-16 |
Axovant Sciences Ltd. | AXON | Corcoran Gavin VP |
250,000 | $2.46 | 250,000 (Direct) |
View |
| 2018-07-16 Option Award |
2018-07-20 6:23 pm |
N/A 2028-07-16 |
Axovant Sciences Ltd. | AXON | Corcoran Gavin VP |
200,000 | $2.46 | 250,000 (Direct) |
View |
| 2018-03-15 Option Award |
2018-03-16 6:34 pm |
N/A 2028-03-15 |
Axovant Sciences Ltd. | AXON | Pande Atul Director |
75,000 | $1.46 | 75,000 (Direct) |
View |
| 2018-03-15 Option Award |
2018-03-16 6:33 pm |
N/A 2028-03-15 |
Axovant Sciences Ltd. | AXON | Weinhoff Gregory M Principal Financial Officer |
700,000 | $1.46 | 700,000 (Direct) |
View |
| 2018-03-15 Option Award |
2018-03-16 6:33 pm |
N/A 2028-03-15 |
Axovant Sciences Ltd. | AXON | Weinhoff Gregory M Principal Financial Officer |
450,000 | $1.46 | 700,000 (Direct) |
View |
| 2018-03-15 Option Award |
2018-03-16 6:33 pm |
N/A 2028-03-15 |
Axovant Sciences Ltd. | AXON | Modig Berndt Director |
75,000 | $1.46 | 75,000 (Direct) |
View |
| 2018-03-15 Option Award |
2018-03-16 6:32 pm |
N/A 2028-03-15 |
Axovant Sciences Ltd. | AXON | Altmeyer Mark Pres (ASG) & Chief Comm. Ofc. |
340,000 | $1.46 | 340,000 (Direct) |
View |
| 2018-03-15 Option Award |
2018-03-16 6:32 pm |
N/A 2028-03-15 |
Axovant Sciences Ltd. | AXON | Altmeyer Mark Pres (ASG) & Chief Comm. Ofc. |
100,000 | $1.46 | 340,000 (Direct) |
View |
| 2018-03-15 Option Award |
2018-03-16 6:31 pm |
N/A 2028-03-15 |
Axovant Sciences Ltd. | AXON | Mohr Stephen Frederick General Counsel |
250,000 | $1.46 | 250,000 (Direct) |
View |
| 2018-03-15 Option Award |
2018-03-16 6:31 pm |
N/A 2028-03-15 |
Axovant Sciences Ltd. | AXON | Mohr Stephen Frederick General Counsel |
100,000 | $1.46 | 250,000 (Direct) |
View |
| 2018-02-13 Option Award |
2018-02-15 5:45 pm |
N/A 2028-02-12 |
Axovant Sciences Ltd. | AXON | JEFFS ROGER Director |
150,000 | $1.81 | 150,000 (Direct) |
View |
| 2018-02-13 Option Award |
2018-02-15 5:44 pm |
N/A 2028-02-12 |
Axovant Sciences Ltd. | AXON | Bickerstaff George Director |
150,000 | $1.81 | 150,000 (Direct) |
View |
| 2018-02-13 Option Award |
2018-02-15 5:43 pm |
N/A 2028-02-12 |
Axovant Sciences Ltd. | AXON | Cheruvu Pavan CEO |
1,940,185 | $1.81 | 1,940,185 (Direct) |
View |
| 2017-12-29 Exercise |
2018-01-03 08:48 am |
N/A 2027-12-29 |
Axovant Sciences Ltd. | AXON | Hung David Director |
2,000,000 | $5.27 | 2,000,000 (Direct) |
View |
| 2017-12-29 Exercise |
2018-01-03 08:39 am |
N/A N/A |
Axovant Sciences Ltd. | AXON | Modig Berndt Director |
77,914 | $0.9 | 77,914 (Direct) |
View |
| 2017-12-29 Exercise |
2018-01-03 08:39 am |
N/A 2025-03-17 |
Axovant Sciences Ltd. | AXON | Modig Berndt Director |
77,914 | $0.9 | 77,914 (Direct) |
View |
| 2017-07-17 Option Award |
2017-07-19 12:38 pm |
N/A 2027-07-16 |
Axovant Sciences Ltd. | AXON | Machado Patrick Director, 10% Owner |
70,000 | $23.67 | 70,000 (Direct) |
View |
| 2017-06-15 Option Award |
2017-06-16 6:25 pm |
N/A 2027-06-14 |
Axovant Sciences Ltd. | AXON | Mohr Stephen Frederick General Counsel |
187,400 | $20.72 | 187,400 (Direct) |
View |
| 2017-05-15 Option Award |
2017-05-16 5:09 pm |
N/A 2027-05-14 |
Axovant Sciences Ltd. | AXON | VERNON W ANTHONY Director |
70,000 | $21.9 | 70,000 (Direct) |
View |
| 2017-05-15 Option Award |
2017-05-16 5:03 pm |
N/A 2027-05-14 |
Axovant Sciences Ltd. | AXON | FALBERG KATHRYN E Director |
70,000 | $21.9 | 70,000 (Direct) |
View |
| 2017-04-28 Option Award |
2017-05-02 9:07 pm |
N/A 2027-04-28 |
Axovant Sciences Ltd. | AXON | OLANOFF LAWRENCE S Director |
27,000 | $24.24 | 27,000 (Direct) |
View |
| 2017-04-28 Option Award |
2017-05-02 9:05 pm |
N/A 2027-04-28 |
Axovant Sciences Ltd. | AXON | Pisano Gary P. Director |
27,000 | $24.24 | 27,000 (Direct) |
View |
| 2017-04-28 Option Award |
2017-05-02 9:04 pm |
N/A 2027-04-28 |
Axovant Sciences Ltd. | AXON | Modig Berndt Director |
27,000 | $24.24 | 27,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Tue, 20 Aug 2019 10:00:13 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |